NCT05478863View on ClinicalTrials.gov

The Pharmacodynamics of Cannabinoid-Caffeine Combinations

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions
Behavioral Pharmacology of Cannabinoids
Interventions
DRUG

Oral Placebo

Placebo will be orally self-administered by study participants.

DRUG

Oral THC

THC will be orally self-administered by study participants.

DRUG

Oral CBD

CBD will be orally self-administered by study participants.

DRUG

Oral Caffeine

Caffeine will be orally self-administered by study participants.

Trial Locations (1)

21224

Johns Hopkins University School of Medicine BPRU, Baltimore

All Listed Sponsors
collaborator

Canopy Growth Corporation

INDUSTRY

lead

Johns Hopkins University

OTHER